Yonatan Y. Mahller

835 total citations
15 papers, 688 citations indexed

About

Yonatan Y. Mahller is a scholar working on Genetics, Neurology and Oncology. According to data from OpenAlex, Yonatan Y. Mahller has authored 15 papers receiving a total of 688 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Genetics, 6 papers in Neurology and 6 papers in Oncology. Recurrent topics in Yonatan Y. Mahller's work include Virus-based gene therapy research (9 papers), CAR-T cell therapy research (6 papers) and Neuroblastoma Research and Treatments (5 papers). Yonatan Y. Mahller is often cited by papers focused on Virus-based gene therapy research (9 papers), CAR-T cell therapy research (6 papers) and Neuroblastoma Research and Treatments (5 papers). Yonatan Y. Mahller collaborates with scholars based in United States, Switzerland and Netherlands. Yonatan Y. Mahller's co-authors include Timothy P. Cripe, Nancy Ratner, Margaret H. Collins, Mark A. Currier, William H. Baird, Yoshinaga Saeki, José A. Cancelas, Timothy M. Crombleholme, Sachin S. Vaikunth and Lisa C. Adams and has published in prestigious journals such as PLoS ONE, Cancer Research and Clinical Cancer Research.

In The Last Decade

Yonatan Y. Mahller

14 papers receiving 683 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yonatan Y. Mahller United States	12	313	269	253	249	140	15	688
Donna Rill United States	17	285 0.9×	418 1.6×	229 0.9×	229 0.9×	69 0.5×	22	783
Hirokazu Kambara Japan	12	371 1.2×	233 0.9×	313 1.2×	67 0.3×	191 1.4×	17	694
Andrea Muscat Australia	11	233 0.7×	384 1.4×	473 1.9×	52 0.2×	58 0.4×	15	970
Babak Moghimi United States	14	399 1.3×	474 1.8×	493 1.9×	101 0.4×	60 0.4×	23	1.0k
Justin C. Roth United States	14	392 1.3×	394 1.5×	403 1.6×	28 0.1×	132 0.9×	25	800
William Siders United States	15	176 0.6×	266 1.0×	274 1.1×	77 0.3×	41 0.3×	26	875
Hongshan Zhao China	18	113 0.4×	124 0.5×	544 2.2×	68 0.3×	67 0.5×	42	843
Alessia Cavazza Italy	15	319 1.0×	306 1.1×	543 2.1×	24 0.1×	63 0.5×	39	850
Christopher Alvarez‐Breckenridge United States	18	348 1.1×	531 2.0×	369 1.5×	23 0.1×	154 1.1×	52	1.2k
Federico La Manna Italy	13	147 0.5×	271 1.0×	269 1.1×	26 0.1×	48 0.3×	27	740

Countries citing papers authored by Yonatan Y. Mahller

Since Specialization

Citations

This map shows the geographic impact of Yonatan Y. Mahller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yonatan Y. Mahller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yonatan Y. Mahller more than expected).

Fields of papers citing papers by Yonatan Y. Mahller

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yonatan Y. Mahller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yonatan Y. Mahller. The network helps show where Yonatan Y. Mahller may publish in the future.

Co-authorship network of co-authors of Yonatan Y. Mahller

This figure shows the co-authorship network connecting the top 25 collaborators of Yonatan Y. Mahller. A scholar is included among the top collaborators of Yonatan Y. Mahller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yonatan Y. Mahller. Yonatan Y. Mahller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Mahller, Yonatan Y., et al.. (2012). Peri-operative ketorolac is associated with improved epithelial ovarian cancer survival. Gynecologic Oncology. 127(1). S25–S25. 2 indexed citations

Ogunyemi, Dotun, et al.. (2011). Associations between DISC assessment and performance in obstetrics and gynecology residents.. PubMed. 56(9-10). 398–404. 4 indexed citations

Jegga, Anil G., et al.. (2010). Molecular engineering and validation of an oncolytic herpes simplex virus type 1 transcriptionally targeted to midkine‐positive tumors. The Journal of Gene Medicine. 12(7). 613–623. 17 indexed citations

Kaimal, Vinod, Zhengtao Chu, Yonatan Y. Mahller, et al.. (2010). Saposin C Coupled Lipid Nanovesicles Enable Cancer-Selective Optical and Magnetic Resonance Imaging. Molecular Imaging and Biology. 13(5). 886–897. 24 indexed citations

Qi, Xiaoyang, Zhengtao Chu, Yonatan Y. Mahller, et al.. (2009). Cancer-Selective Targeting and Cytotoxicity by Liposomal-Coupled Lysosomal Saposin C Protein. Clinical Cancer Research. 15(18). 5840–5851. 52 indexed citations

Mahller, Yonatan Y., Jon Williams, William H. Baird, et al.. (2009). Neuroblastoma Cell Lines Contain Pluripotent Tumor Initiating Cells That Are Susceptible to a Targeted Oncolytic Virus. PLoS ONE. 4(1). e4235–e4235. 112 indexed citations

Cripe, Timothy P., et al.. (2009). Targeting Cancer-initiating Cells With Oncolytic Viruses. Molecular Therapy. 17(10). 1677–1682. 62 indexed citations

Mahller, Yonatan Y. & Timothy P. Cripe. (2009). Targeting cancer cells with stem cell-like properties: the key to preventing recurrence in neuroblastoma?. Therapy. 6(3). 297–299.

Johansson, Gunnar, Yonatan Y. Mahller, Margaret H. Collins, et al.. (2008). Effective in vivo targeting of the mammalian target of rapamycin pathway in malignant peripheral nerve sheath tumors. Molecular Cancer Therapeutics. 7(5). 1237–1245. 104 indexed citations

10.

Mahller, Yonatan Y., Sachin S. Vaikunth, William H. Baird, et al.. (2008). Tissue Inhibitor of Metalloproteinase-3 via Oncolytic Herpesvirus Inhibits Tumor Growth and Vascular Progenitors. Cancer Research. 68(4). 1170–1179. 74 indexed citations

11.

Currier, Mark A., Rebecca A. Gillespie, Nancy Sawtell, et al.. (2008). Efficacy and Safety of the Oncolytic Herpes Simplex Virus rRp450 Alone and Combined With Cyclophosphamide. Molecular Therapy. 16(5). 879–885. 57 indexed citations

12.

Mahller, Yonatan Y., Sachin S. Vaikunth, Mark A. Currier, et al.. (2007). Oncolytic HSV and Erlotinib Inhibit Tumor Growth and Angiogenesis in a Novel Malignant Peripheral Nerve Sheath Tumor Xenograft Model. Molecular Therapy. 15(2). 279–286. 76 indexed citations

13.

Mahller, Yonatan Y., Fatima Rangwala, Nancy Ratner, & Timothy P. Cripe. (2005). Malignant peripheral nerve sheath tumors with high and low Ras‐GTP are permissive for oncolytic herpes simplex virus mutants. Pediatric Blood & Cancer. 46(7). 745–754. 33 indexed citations

14.

Currier, Mark A., Lisa C. Adams, Yonatan Y. Mahller, & Timothy P. Cripe. (2005). Widespread intratumoral virus distribution with fractionated injection enables local control of large human rhabdomyosarcoma xenografts by oncolytic herpes simplex viruses. Cancer Gene Therapy. 12(4). 407–416. 37 indexed citations

15.

Parikh, Nehal S., Mark A. Currier, Yonatan Y. Mahller, et al.. (2004). Oncolytic herpes simplex virus mutants are more efficacious than wild‐type adenovirus Type 5 for the treatment of high‐risk neuroblastomas in preclinical models. Pediatric Blood & Cancer. 44(5). 469–478. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact